Browse studies

Find your next paid study

13 recruiting studies matching your filters

Phase I/II Study to Evaluate the Safety and Preliminary Efficacy of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

This is a phase 1/2 clinical study to evaluate the safety, preliminary efficacy, immunogenicity, and pharmacokinetic (PK) characteristics of SKG0106 in subject…

Neovascular Age-related Macular Degeneration

Estimated

~$10 – $8,750

Skyline Therapeutics (US) Inc.NCT05986864